Updated hourlyHourly refreshTue, Sep 8, 2026
Press Release Database
Recent press releases, indexed by topic.
Finance · Healthcare
ARLINGTON, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Kala Bio, Inc. (Nasdaq: KALA) ("Kala") and Virotek Inc. ("Virotek"), a CLIA-registered precision health and clinical genomics company, today announced that they have entered into a letter of intent (the "LOI") outlining the principal terms under which the companies intend to negotiate a definitive agreement appointing Kala as the exclusive distributor and reseller in the United States of Virotek's genetic testing and screening program for ophthalmological indications.
Sep 1 · 11:45·GlobeNewswire
Finance · Healthcare
Vancouver, Canada, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (the “Company”), a clinical-stage biopharmaceutical company advancing non-hallucinogenic psychedelic-derived neuroplastogen for scalable treatment of neuropsychiatric, metabolic, and addiction disorders including Alcohol Use Disorder (“AUD”), announced today the initiation of Phase lla, the next stage of its double-blind, placebo-controlled Phase I/IIa clinical trial evaluating CMND-100 for the treatment of AUD, with six patients enrolled to date. Three participants have been enrolled at Tel Aviv Sourasky Medical Center (TASMC) and three at Hadassah Medical Center in Jerusalem, initiating the first multiple-dose treatment phase of Part C (“phase IIa”) following the successful completion of the tria
Sep 1 · 11:37·GlobeNewswire
Finance · Healthcare
NEW YORK, September 01, 2026--DocGo Inc. (Nasdaq: DCGO) ("DocGo"), a leading provider of technology-enabled mobile health and medical transportation services, announced today that Lee Bienstock, Chief Executive Officer, will participate in 1x1 meetings at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday September 16th, and will deliver a fireside presentation at 12:20 PM ET on that day. A webcast of the event will be available on the investor relations section of DocGo’s
Sep 1 · 11:35·mlpr-businesswire
Finance · Healthcare
WALTHAM, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Ardelyx Inc. (Nasdaq: ARDX), (“Ardelyx” or the “Company”) a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced its participation in the following investor conferences:
Sep 1 · 11:30·GlobeNewswire
Finance · Healthcare
PALO ALTO, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for genetic conditions, today announced that members of its management team will participate in fireside chats at the following healthcare investor conferences:
Sep 1 · 11:30·GlobeNewswire
Finance · Healthcare
AUSTIN, Texas, September 01, 2026--Faeth Therapeutics (Nasdaq: FTH), a clinical-stage oncology company developing multi-node therapies for cancer patients, including its lead program PIKTOR, today announced that management will participate in the following upcoming investor conferences:
Sep 1 · 11:30·mlpr-businesswire
Healthcare
Paxalisib Monotherapy Significantly Reduced Tumor Burden in Pre-Clinical Model of MSS/pMMR Colorectal Cancer, With the Addition of Pembrolizumab Driving a Further Reduction Paxalisib Was Well Tolerated as Monotherapy and in Combination with Checkpoint Inhibition Kazia is Preparing to...
Sep 1 · 11:30·PR Newswire
Healthcare
Monthlong campaign in September aims to elevate awareness of hand health, encourage early detection of Dupuytren's contracture, and connect patients with appropriate care DUBLIN, Sept. 1, 2026 /PRNewswire/ -- Keenova Therapeutics plc today announced plans for the 2nd Annual National Hand...
Sep 1 · 11:30·PR Newswire
Finance · Healthcare
BEDFORD, Mass. & CAMBRIDGE, Mass., September 01, 2026--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine, and Biogen Inc.
Sep 1 · 11:30·mlpr-businesswire
Healthcare
Free 2-day online event brings together leading experts to unite functional and longevity medicine with cutting-edge science and clinical tools
Sep 1 · 11:07·Newswire.com
Healthcare
OSLO, Norway & BOSTON, September 01, 2026--Calluna Pharma Announces Participation in Upcoming Conferences to highlight Phase 2 AURORA study of CAL101 in IPF ahead of planned Q1 2027 readout
Sep 1 · 11:02·mlpr-businesswire
Healthcare · Education
(PR-inside.com) Leading physicians, scientists, regulatory experts, and healthcare innovators will convene October 23-25 at Fort Lauderdale's Pier Sixty-Six Resort + Marina for three days of regenerative medicine education, hands-on clinical training, and interdisciplinary collaboration FORT LAUDERDALE, FL / ACCESS Newswire / September 1, 2026 / ZEO ScientifiX, Inc. (OTCQB:ZEOX) ("ZEO ScientifiX" or the "Company") today announced the multidisciplinary faculty and guest speaker lineup for the inaugural ZEO Xperience, a three-day immersive regenerative medicine event for healthcare professionals taking place October 23-25, 2026, at Pier Sixty-Six Resort + Marina in Fort Lauderdale, Florida. Bringing together physicians, scientists, regulatory professionals, clinical educators, and healthcare
Sep 1 · 11:01·PR-Inside